LNAI
Lunai Bioworks
LNAI
LNAI
41 hedge funds and large institutions have $19.2M invested in Lunai Bioworks in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
14
Reduced
8
Closed
10
Calls
$133K
Puts
$42K
Net Calls
+$91K
Net Calls Change
+$9K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.35M |
| 2 |
Goldman Sachs
New York
|
+$777K |
| 3 |
Millennium Management
New York
|
+$443K |
| 4 |
Citigroup
New York
|
+$362K |
| 5 |
Man Group
London,
United Kingdom
|
+$286K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$929K |
| 2 |
6CM
683 Capital Management
New York
|
-$234K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$118K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$118K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$64.7K |
